The metal transporter SMF-3/DMT-1 mediates aluminum-induced dopamine neuron degeneration

Journal of Neurochemistry

Volumn 124, Issue 1, 2013, Pages 147-157

  Vanduyn, Natalia ^a   Settivari, Raja ^a   Levora, Jennifer ^a   Zhou, Shaoyu ^a   Unrine, Jason ^b   Nass, Richard ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

C. elegans; Nrf2 SKN 1; Parkinson's disease

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA SYNUCLEIN; ALUMINUM; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; SMF3 PROTEIN; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CAENORHABDITIS ELEGANS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOWN REGULATION; EMBRYO; INTRACELLULAR TRANSPORT; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOSINE TRIPHOSPHATE; ALUMINUM; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CALCIUM-BINDING PROTEINS; CATION TRANSPORT PROTEINS; DNA-BINDING PROTEINS; DOPAMINERGIC NEURONS; HUMANS; MASS SPECTROMETRY; MEMBRANE POTENTIAL, MITOCHONDRIAL; NERVE DEGENERATION; TRANSCRIPTION FACTORS; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; CAENORHABDITIS ELEGANS;

EID: 84870932163     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12072     Document Type: Article

References (60)

1. Altschul S. F., (1991) Amino acid substitution matrices from an information theoretic perspective. J. Mol. Biol. 219, 555-565.
2. Banasik A., Lankoff A., Piskulak A., Adamowska K., Lisowska H., and, Wojcik A., (2005) Aluminum-induced micronuclei and apoptosis in human peripheral-blood lymphocytes treated during different phases of the cell cycle. Environ. Toxicol. 20, 402-406. (Pubitemid 41176677)
3. Bandyopadhyay J., Song H. O., Park B. J., Singaravelu G., Sun J. L., Ahnn J., and, Cho J. H., (2009) Functional assessment of Nramp-like metal transporters and manganese in Caenorhabditis elegans. Biochem. Biophys. Res. Commun. 390, 136-141.
4. Becaria A., Campbell A., and, Bondy S. C., (2002) Aluminum as a toxicant. Toxicol. Ind. Health 18, 309-320. (Pubitemid 38352147)
5. Bharathi P., and, Rao K. S., (2008) Molecular understanding of copper and iron interaction with alpha-synuclein by fluorescence analysis. J. Mol. Neurosci. 35, 273-281.
6. Bianchi L., and, Driscoll M., (2006) Culture of embryonic C. elegans cells for electrophysiological and pharmacological analyses. (September 30, 2006), WormBook, ed. The C. elegans Research Community, WormBook, doi/ 10.1895/wormbook.1.122.1, http://www.wormbook.org
7. Brenner S., (1974) The genetics of Caenorhabditis elegans. Genetics 77, 71-94.
8. Burdo J. R., Menzies S. L., Simpson I. A., Garrick L. M., Garrick M. D., Dolan K. G., Haile D. J., Beard J. L., and, Connor J. R., (2001) Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J. Neurosci. Res. 66, 1198-1207. (Pubitemid 33135606)
9. Carvelli L., McDonald P. W., Blakely R. D., and, Defelice L. J., (2004) Dopamine transporters depolarize neurons by a channel mechanism. Proc. Natl Acad. Sci. USA 101, 16046-16051. (Pubitemid 39507924)
10. Cellier M., Prive G., Belouchi A., Kwan T., Rodrigues V., Chia W., and, Gros P., (1995) Nramp defines a family of membrane proteins. Proc. Natl Acad. Sci. USA 92, 10089-10093.
11. Chew K. C., Ang E. T., Tai Y. K., et al,. (2011) Enhanced autophagy from chronic toxicity of iron and mutant A53T alpha-synuclein: implications for neuronal cell death in Parkinson disease. J. Biol. Chem. 286, 33380-33389.
12. Cooper A. A., Gitler A. D., Cashikar A., et al,. (2006) Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313, 324-328. (Pubitemid 44480951)
13. Crisponi G., Nurchi V., Faa F., and, Remelli M., (2011) Human diseases related to aluminium overload. Monatsh. Chem. 142, 331-340.
14. Ehrenberg B., Montana V., Wei M. D., Wuskell J. P., and, Loew L. M., (1988) Membrane potential can be determined in individual cells from the nernstian distribution of cationic dyes. Biophys. J. 53, 785-794.
15. Erazi H., Ahboucha S., and, Gamrani H., (2011) Chronic exposure to aluminum reduces tyrosine hydroxylase expression in the substantia nigra and locomotor performance in rats. Neurosci. Lett. 487, 8-11.
16. Greger J. L., (1993) Aluminum metabolism. Annu. Rev. Nutr. 13, 43-63. (Pubitemid 23227776)
17. Hirsch E. C., Brandel J. P., Galle P., Javoy-Agid F., and, Agid Y., (1991) Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J. Neurochem. 56, 446-451. (Pubitemid 21901982)
18. Hope I., (1999) C. elegans: A Practical Approach. Oxford University Press, New York.
19. Kamath R. S., and, Ahringer J., (2003) Genome-wide RNAi screening in Caenorhabditis elegans. Methods 30, 313-321. (Pubitemid 36793968)
20. Kawahara M., and, Kato-Negishi M., (2011) Link between Aluminum and the Pathogenesis of Alzheimer's Disease: The Integration of the Aluminum and Amyloid Cascade Hypotheses. Int. J. Alzheimers Dis. 2011, 276393.
21. Kumar V., Bal A., and, Gill K. D., (2008) Impairment of mitochondrial energy metabolism in different regions of rat brain following chronic exposure to aluminium. Brain Res. 1232, 94-103.
22. Kumar V., Bal A., and, Gill K. D., (2009) Aluminium-induced oxidative DNA damage recognition and cell-cycle disruption in different regions of rat brain. Toxicology 264, 137-144.
23. Lakso M., Vartiainen S., Moilanen A. M., Sirvio J., Thomas J. H., Nass R., Blakely R. D., and, Wong G., (2003) Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein. J. Neurochem. 86, 165-172. (Pubitemid 36753857)
24. Larkin M. A., Blackshields G., Brown N. P., et al,. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947-2948. (Pubitemid 350162903)
25. Lastres-Becker I., Ulusoy A., Innamorato N. G., Sahin G., Rabano A., Kirik D., and, Cuadrado A., (2012) alpha-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease. Hum. Mol. Genet. 21, 3173-3192.
26. Lemire J., Mailloux R., Puiseux-Dao S., and, Appanna V. D., (2009) Aluminum-induced defective mitochondrial metabolism perturbs cytoskeletal dynamics in human astrocytoma cells. J. Neurosci. Res. 87, 1474-1483.
27. Luk E. E., and, Culotta V. C., (2001) Manganese superoxide dismutase in Saccharomyces cerevisiae acquires its metal co-factor through a pathway involving the Nramp metal transporter, Smf2p. J. Biol. Chem. 276, 47556-47562.
28. Lukiw W. J., Percy M. E., and, Kruck T. P., (2005) Nanomolar aluminum induces pro-inflammatory and pro-apoptotic gene expression in human brain cells in primary culture. J. Inorg. Biochem. 99, 1895-1898. (Pubitemid 41253779)
29. Martin R. B., (1986) The chemistry of aluminum as related to biology and medicine. Clin. Chem. 32, 1797-1806. (Pubitemid 17018049)
30. Nass R., and, Blakely R. D., (2003) The Caenorhabditis elegans dopaminergic system: opportunities for insights into dopamine transport and neurodegeneration. Annu. Rev. Pharmacol. Toxicol. 43, 521-544. (Pubitemid 37372652)
31. Nass R., and, Hamza I., (2007) The nematode Caenorhabditis elegans as a model to explore toxicology in vivo: solid and axenic growth culture conditions and compound exposure parameters. Curr. Protoc. Toxicol. 31, 1.9.1-1.9.18.
32. Nass R., and, Settivari R. S., (2008) Caenorhabditis elegans models of Parkinson's disease: a robust genetic system to identify and characterize endogenous and environmental components involved in dopamine neuron degeneration, in Parkinson's Disease: Molecular and Therapeutic Insights from Model Systems (, Nass R., and, Przedborski S., eds), pp. 347-360. Elsevier Academic Press, New York, NY.
33. Nass R., Miller D. M., and, Blakely R. D., (2001) C. elegans: a novel pharmacogenetic model to study Parkinson's disease. Parkinsonism Relat. Disord. 7, 185-191. (Pubitemid 32372500)
34. Nass R., Hall D. H., Miller D. M. III, and, Blakely R. D., (2002) Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 99, 3264-3269. (Pubitemid 34240620)
35. Nass R., Merchant K. M., and, Ryan T., (2008) Caenohabditis elegans in Parkinson's disease drug discovery: addressing an unmet medical need. Mol. Interv. 8, 284-293.
36. Papp-Wallace K. M., and, Maguire M. E., (2006) Manganese transport and the role of manganese in virulence. Annu. Rev. Microbiol. 60, 187-209. (Pubitemid 44627946)
37. Petrik M. S., Wong M. C., Tabata R. C., Garry R. F., and, Shaw C. A., (2007) Aluminum adjuvant linked to Gulf War illness induces motor neuron death in mice. Neuromolecular Med. 9, 83-100. (Pubitemid 44772277)
38. Portnoy M. E., Liu X. F., and, Culotta V. C., (2000) Saccharomyces cerevisiae expresses three functionally distinct homologues of the nramp family of metal transporters. Mol. Cell. Biol. 20, 7893-7902.
39. Portnoy M. E., Jensen L. T., and, Culotta V. C., (2002) The distinct methods by which manganese and iron regulate the Nramp transporters in yeast. Biochem. J. 362, 119-124. (Pubitemid 34176798)
40. Salazar J., Mena N., Hunot S., et al,. (2008) Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease. Proc. Natl Acad. Sci. USA 105, 18578-18583.
41. Sanchez-Iglesias S., Mendez-Alvarez E., Iglesias-Gonzalez J., Munoz-Patino A., Sanchez-Sellero I., Labandeira-Garcia J. L., and, Soto-Otero R., (2009) Brain oxidative stress and selective behaviour of aluminium in specific areas of rat brain: potential effects in a 6-OHDA-induced model of Parkinson's disease. J. Neurochem. 109, 879-888.
42. Settivari R., LeVora J., and, Nass R., (2009) The divalent metal transporter homologues SMF-1/2 mediate dopamine neuron sensitivity in caenorhabditis elegans models of manganism and parkinson disease. J. Biol. Chem. 284, 35758-35768.
43. Timmons L., and, Fire A., (1998) Specific interference by ingested dsRNA. Nature 395, 854.
44. Toninello A., Clari G., Mancon M., Tognon G., and, Zatta P., (2000) Aluminum as an inducer of the mitochondrial permeability transition. J. Biol. Inorg. Chem. 5, 612-623.
45. Uversky V. N., Li J., and, Fink A. L., (2001) Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. J. Biol. Chem. 276, 44284-44296.
46. VanDuyn N., Settivari R., Wong G., and, Nass R., (2010) SKN-1/Nrf2 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of methylmercury toxicity. Toxicol. Sci. 118, 613-624.
47. Vartiainen S., Pehkonen P., Lakso M., Nass R., and, Wong G., (2006) Identification of gene expression changes in transgenic C. elegans overexpressing human alpha-synuclein. Neurobiol. Dis. 22, 477-486. (Pubitemid 43832121)
48. Vasudevaraju P., Govindaraju M., Palanisamy A. P., Sambamurti K., and, Rao K. S., (2008) Molecular toxicity of aluminium in relation to neurodegeneration. Indian J. Med. Res. 128, 545-556.
49. Verstraeten S. V., Aimo L., and, Oteiza P. I., (2008) Aluminium and lead: molecular mechanisms of brain toxicity. Arch. Toxicol. 82, 789-802.
50. Walton J. R., (2012) Cognitive deterioration and associated pathology induced by chronic low-level aluminum ingestion in a translational rat model provides an explanation of Alzheimer's disease, tests for susceptibility and avenues for treatment. Int. J. Alzheimers Dis. 2012, 914947.
51. Wu Z., Du Y., Xue H., Wu Y., and, Zhou B., (2012) Aluminum induces neurodegeneration and its toxicity arises from increased iron accumulation and reactive oxygen species (ROS) production. Neurobiol. Aging 33, 199. e1-12.
52. Xia J., Yamaji N., Kasai T., and, Ma J. F., (2010) Plasma membrane-localized transporter for aluminum in rice. Proc. Natl Acad. Sci. USA 107, 18381-18385.
53. Yasui M., Kihira T., and, Ota K., (1992) Calcium, magnesium and aluminum concentrations in Parkinson's disease. Neurotoxicology 13, 593-600.
54. Yokel R. A., (2002) Brain uptake, retention, and efflux of aluminum and manganese. Environ. Health Perspect. 110 (Suppl 5), 699-704. (Pubitemid 35276852)
55. Yokel R. A., (2006) Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration. J. Alzheimers Dis. 10, 223-253. (Pubitemid 44763995)
56. Yoneda T., Benedetti C., Urano F., Clark S. G., Harding H. P., and, Ron D., (2004) Compartment-specific perturbation of protein handling activates genes encoding mitochondrial chaperones. J. Cell Sci. 117, 4055-4066. (Pubitemid 39328294)
57. Zatta P., Lucchini R., van Rensburg S. J., and, Taylor A., (2003) The role of metals in neurodegenerative processes: aluminum, manganese, and zinc. Brain Res. Bull. 62, 15-28. (Pubitemid 37330111)
58. Zayed J., Campanella G., Panisset J. C., Ducic S., Andre P., Masson H., and, Roy M., (1990a) Parkinson disease and environmental factors. Rev. Epidemiol. Sante Publique, 38, 159-160.
59. Zayed J., Ducic S., Campanella G., Panisset J. C., Andre P., Masson H., and, Roy M., (1990b) Environmental factors in the etiology of Parkinson's disease. Can. J. Neurol. Sci., 17, 286-291. (Pubitemid 20254751)
60. Zhang S., Wang J., Song N., Xie J., and, Jiang H., (2009) Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells. Neurobiol. Aging 30, 1466-1476.